Hypha Labs, Inc 8-K, filed Jan 30, 2026
Hypha Labs, Inc. (FUNI)
About this 8-K
Hypha Labs, Inc filed this 8-K on January 30, 2026, reporting on events of January 27, 2026.
Items reported
- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact Name of Small Business Issuer as Specified in Its Charter)
State or Other Jurisdiction of Incorporation of Organization) |
(Commission File Number) |
(IRS Employer Identification Number) |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s
telephone number, including area code:
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 4.01 | Changes in Registrant’s Certifying Accountant. |
The Board of Directors of Hypha Labs, Inc. (the “Company”) conducted a search to determine the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 30, 2026.
On January 27, 2026, the Board approved: (i) the engagement of Astra Audit and Advisory, LLC (“Astra”) as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 30, 2026; and (ii) the dismissal of Fruci & Associates II, PLLC (“Fruci”), the Company’s current independent registered public accounting firm.
Fruci’s reports on the Company’s financial statements for the fiscal years ended September 30, 2024 and 2025 did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified to audit scope or accounting principles but did include explanatory paragraphs and footnotes questioning the Company’s ability to continue as a going concern. During the period of Fruci’s engagement as the Company’s independent registered public accounting firm, there were no disagreements as defined in Item 304 of Regulation S-K on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Fruci would have caused it to make reference in connection with any opinion to the subject matter of the disagreement. Furthermore, during the engagement of Fruci, there were no reportable events, as defined under Item 304(a)(1)(v) of Regulation S-K.
The Company has requested that Fruci furnish a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the above statements contained in this Form 8-K. A copy of this letter is filed as Exhibit 16.1 to this report.
During the fiscal years ended September 30, 2024 and September 30, 2025 and the subsequent interim periods through December 31, 2025, neither the Company nor anyone on its behalf has consulted with Astra regarding either: (i) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that Astra concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue; (ii) any matter that was the subject of a disagreement within the meaning of Item 304(a)(1)(iv) of Regulation S-K and the related instructions; or (iii) any matter that was a reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K.
| Item 9.01 | Financial Statements and Exhibits |
| (d) | Exhibits |
| 16.1 | Letter From Fruci & Associates II, PLLC |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HYPHA LABS, INC. | |
| Dated: January 30, 2026 | /s/ A. Stone Douglas |
| A. Stone Douglas | |
| Chief Executive Officer |
Exhibit 16.1
| January 29, 2026 | |
 |
Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549
Dear Sirs/Madams: |
| RE: | Hypha Labs, Inc. | |
Members of: WSCPA AICPA
802 N Washington PO Box 2163 Spokane, Washington 99210-2163
P 509-624-9223 mail@fruci.com www.fruci.com | We have read Item 4.01 of Hypha Labs, Inc.’s Form 8-K dated January 27, 2026, and we agree with the statements set forth in Item 4.01, insofar as they relate to our firm. We have no basis to agree or disagree with the other statements contained therein.
Yours truly,
Fruci & Associates II, PLLC | |
| 1 |